Navigating the landscape: Prospects and hurdles in targeting vascular smooth muscle cells for atherosclerosis diagnosis and therapy
J He, Y Gao, C Yang, Y Guo, L Liu, S Lu… - Journal of Controlled …, 2024 - Elsevier
Vascular smooth muscle cells (VSMCs) have emerged as pivotal contributors throughout all
phases of atherosclerotic plaque development, effectively dispelling prior underestimations …
phases of atherosclerotic plaque development, effectively dispelling prior underestimations …
Fluorinated MRI contrast agents and their versatile applications in the biomedical field
E Hequet, C Henoumont, RN Muller… - Future medicinal …, 2019 - Taylor & Francis
MRI has been recognized as one of the most applied medical imaging techniques in clinical
practice. However, the presence of background signal coming from water protons in …
practice. However, the presence of background signal coming from water protons in …
Arterial inflammation in young patients with human immunodeficiency virus infection: a cross-sectional study using F-18 FDG PET/CT
IO Lawal, AO Ankrah, GO Popoola, T Lengana… - Journal of Nuclear …, 2019 - Elsevier
Background HIV infection is associated with the risk of development of atherosclerosis at a
younger age. We compared arterial inflammation in HIV-infected and HIV-uninfected …
younger age. We compared arterial inflammation in HIV-infected and HIV-uninfected …
[HTML][HTML] Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment
AB Blanken, R Agca, AM van Sijl, AE Voskuyl… - Seminars in arthritis and …, 2021 - Elsevier
Background Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular
disease (CVD), partly due to an increased prevalence of cardiovascular risk factors, but also …
disease (CVD), partly due to an increased prevalence of cardiovascular risk factors, but also …
[18F]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging
C De Dominicis, P Perrotta, S Dall'Angelo… - ACS Medicinal …, 2020 - ACS Publications
PFKFB3, a glycolysis-related enzyme upregulated in inflammatory conditions and
angiogenesis, is an emerging target for diagnosis and therapy of atherosclerosis. The …
angiogenesis, is an emerging target for diagnosis and therapy of atherosclerosis. The …
Future growth and success of nuclear cardiology
GA Beller - Journal of Nuclear Cardiology, 2018 - Springer
About 6 months ago, I reviewed a manuscript, and subsequently wrote an editorial, 1
pertaining to a retrospective study undertaken by Mayo Clinic investigators, reporting a …
pertaining to a retrospective study undertaken by Mayo Clinic investigators, reporting a …
Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic …
WA AlJaroudi, FG Hage - Journal of Nuclear Cardiology, 2018 - Elsevier
Several original articles and editorials have been published in the Journal of Nuclear
Cardiology in 2017. It has become a tradition at the beginning of each year to summarize …
Cardiology in 2017. It has become a tradition at the beginning of each year to summarize …
Molecular Imaging of Atheroma: Deciphering How and When to Use 18F-Sodium Fluoride and 18F-Fluorodeoxyglucose
of active microcalcification within the atheroma. Vascular calcification has long been known
to associate with cardiovascular risk. Larger deposits of calcium can be detected with CT …
to associate with cardiovascular risk. Larger deposits of calcium can be detected with CT …
Synthesis and Evaluation of 11C- and 18F-Labeled SOAT1 Inhibitors as Macrophage Foam Cell Imaging Agents
PD-132301, an inhibitor of sterol O-acyltransferase 1 (SOAT1; also known as acyl-coenzyme
A: cholesterol acyltransferase-1, ACAT1), is under clinical investigation for numerous …
A: cholesterol acyltransferase-1, ACAT1), is under clinical investigation for numerous …
Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders
Studies in nuclear medicine have shed light on molecular imaging and therapeutic
approaches for oncological and nononcological conditions. Theranostic approaches using …
approaches for oncological and nononcological conditions. Theranostic approaches using …